That's helpful...but I still think its too early to call for BIC, and being the best PI3K-delta in CLL doesn't mean you have a market. Combos with BTK or Mabs could be the answer but those results are 3-4 years out for 1202. By the way IPI-145 achieved 89% nodal response in 2 months, but really we need to be comparing ORR, not nodal. Anything over 50% (with more patients) is competitive, but BIC would need to break 60%.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.